Compare Definium Therapeutics Inc. Common Shares (DFTX) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs D Wave Quantum Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while D Wave Quantum Inc trades at $14.83 (market cap $5.54B). The key difference: D Wave Quantum Inc is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and D Wave Quantum Inc for 32 Days on average.
| DFTX | QBTS | |
|---|---|---|
Market Cap | $4.59B | $5.54B |
Volume | 2,103,937 | 16,671,452 |
Sector | Health | Technology |
52-Week High | $48.45 | $44.78 |
52-Week Low | $10.68 | $12.98 |
Typical Hold Time | 0 Days | 32 Days |
Enterprise Value | $3.55B | $5.04B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
D-Wave Quantum Inc. (QBTS) trades at $15.22, down 3.61% on the day, reflecting a bearish technical trend. The company shows significant financial strain with a net income margin of -2001.59% and negative cash flow from operations. Despite this, all 13 covering analysts maintain a Buy rating with a consensus price target of $34.38, highlighting a stark divergence between current performance and long-term optimism.
The outlook is highly speculative. The potential reward is substantial if D-Wave achieves commercial success in quantum computing, but the risk is extreme due to persistent losses, high cash burn, and multiple ongoing securities fraud investigations, making it suitable only for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
